United States, Texas — Dallas, Texas

United States, Texas is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

United States, Texas has participated in 5 clinical trials.

Therapeutic areas: Includes: Hereditary Angioedema, Epilepsy, Glioma.

Sponsors: CSL Behring, UCB Biopharma S.P.R.L., Institut de Recherches Internationales Servier.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, Texas?

United States, Texas has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, Texas conducted?

United States, Texas has 5 clinical trials on record. Their work covers Includes: Hereditary Angioedema, Epilepsy, Glioma.

Is United States, Texas accredited by Crixeo Health?

United States, Texas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.